Feature Channels: Immunology

Filters close
Released: 22-Nov-2023 1:05 AM EST
مكافحة مرض نقص المناعة البشري المكتسب (الإيدز): لماذا يكمن هدفنا في اكتشاف فيروس نقص المناعة البشري قبل ظهور الأعراض
Mayo Clinic

روتشستر، مينيسوتا – إن فيروس نقص المناعة البشري، الذي يسبب الإيدز (مرض نقص المناعة البشري المكتسب) بإمكانه أن يختفي في الجسم عدة سنوات قبلما تظهر الأعراض. وخلال هذا الوقت، فإنه يقضي على جزء من الجهاز المناعي دون أن نشعر. لذا فإن هدفنا هو اكتشاف فيروس نقص المناعة البشري قبلما تظهر الأعراض، مما يجعل الاختبارات الروتينية ضروريةً كي يعرف المرضى أنهم مصابون وكي يتسنى علاجهم، وهذا ما أوضحته الدكتورة ستيسي ريزا خبيرة الأمراض المُعدية والباحثة في فيروس نقص المناعة البشري لدى مايو كلينك.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Cleveland Clinic Research Finds Sex Differences in  Immune Response and Metabolism Drive Alzheimer’s Disease
Released: 21-Nov-2023 11:05 AM EST
Cleveland Clinic Research Finds Sex Differences in Immune Response and Metabolism Drive Alzheimer’s Disease
Cleveland Clinic

Cleveland Clinic researchers analyzed genes and brain tissue of patients with Alzheimer’s and found that differences in brain immunometabolism – the interactions between the immune system and the ways cells create energy – may contribute to women’s increased risk for the disease and its severity.

Newswise: Promising target for CAR T cells helps cancer trick the immune system
Released: 21-Nov-2023 11:05 AM EST
Promising target for CAR T cells helps cancer trick the immune system
St. Jude Children's Research Hospital

Immunotherapy using modified chimeric antigen receptor (CAR) T cells has greatly improved survival rates for relapsed and recurrent pediatric leukemia and lymphomas, but not brain and solid tumors.

Newswise: Why natural allergen-specific antibodies cannot always protect against allergies
Released: 21-Nov-2023 8:05 AM EST
Why natural allergen-specific antibodies cannot always protect against allergies
Scientific Project Lomonosov

Immunologists found the difference between antibodies that react to birch pollen allergens in healthy people and patients with allergies. The authors also found out why not all classes of antibodies can protect against allergies. The results were published in Allergy.

Newswise: Seven LJI scientists rank among
Released: 17-Nov-2023 2:05 PM EST
Seven LJI scientists rank among "Highly Cited Researchers"
La Jolla Institute for Immunology

Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.

Newswise: St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing
Released: 15-Nov-2023 11:05 AM EST
St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing
St. Jude Children's Research Hospital

St. Jude scientists mapped the gene regulatory networks responsible for progressive differentiation states of tumor-infiltrating T cells, using a technology known as single-cell CRISPR screening to knock out or genetically perturb multiple genes potentially involved.

Newswise: Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center
Released: 15-Nov-2023 10:05 AM EST
Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center
Mount Sinai Health System

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute (IGI) at the Icahn School of Medicine at Mount Sinai have been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health to establish a state-of-the-art center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise: Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
Released: 14-Nov-2023 1:05 PM EST
Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
Roswell Park Comprehensive Cancer Center

A phase 1 clinical trial conducted exclusively at Roswell Park Comprehensive Cancer Center shows that a novel treatment regimen can make immunotherapy more effective in patients with metastatic triple-negative breast cancer (mTNBC).

Newswise: 20231110_Allison_Institute_Symposium.jpg
Released: 14-Nov-2023 12:05 PM EST
Allison Institute hosts inaugural scientific symposium
University of Texas MD Anderson Cancer Center

The James P. Allison Institute at MD Anderson hosted its inaugural scientific symposium on Nov. 10, bringing together more than 400 leading scientists in immunotherapy and immunobiology.

   
Newswise: Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Released: 14-Nov-2023 10:00 AM EST
Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Johns Hopkins Medicine

For years, researchers and clinicians have known that lupus, an autoimmune condition, occurs in women at a rate nine times higher than in men.

Newswise: Cancer stem cells trigger macrophage aging
7-Nov-2023 7:00 PM EST
Cancer stem cells trigger macrophage aging
Hokkaido University

Cancer stem cells cause the aging of macrophages in mice with healthy immune systems, creating conditions for the formation of tumors.

13-Nov-2023 5:05 PM EST
New Antiphospholipid Syndrome Research Findings Presented at ACR Convergence 2023
Hospital for Special Surgery

Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the American College of Rheumatology (ACR) Convergence 2023, the ACR’s annual meeting.

Released: 10-Nov-2023 12:05 PM EST
Gwen Fortune-Blakely Named Chief Membership and Engagement Officer of The American Association of Immunologists
American Association of Immunologists (AAI)

The American Association of Immunologists (AAI) is pleased to announce the appointment of Gwen Fortune-Blakely, M.B.A, CAE, as its new chief membership and engagement officer.

Newswise: New Knowledge Commons to improve understanding of immune system
Released: 9-Nov-2023 2:05 PM EST
New Knowledge Commons to improve understanding of immune system
UT Southwestern Medical Center

UT Southwestern Medical Center will lead a multi-institution effort to gather and assimilate information on the billions of sequences employed by immune receptors of the adaptive immune system. The project, funded by the National Institutes of Health, aims to improve the understanding of immunity and help facilitate the development of improved vaccines and treatments for many diseases.

Newswise: What Human Diseases Can Teach Us About the Immune System
Released: 9-Nov-2023 1:05 PM EST
What Human Diseases Can Teach Us About the Immune System
Harvard Medical School

Jennifer Oyler-Yaniv is studying human diseases to learn about the immune system. She hopes that diseases such as cancer will reveal fundamental principles of how immune cells communicate

8-Nov-2023 4:05 PM EST
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.

Newswise: Nuevo estudio: hacer gárgaras con agua salada podría ayudar a prevenir la hospitalización por COVID
3-Nov-2023 8:00 AM EDT
Nuevo estudio: hacer gárgaras con agua salada podría ayudar a prevenir la hospitalización por COVID
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentará en la Reunión Científica Anual del ACAAI de este año en Anaheim (California) determinó que tanto un régimen de solución salina de dosis baja como de dosis alta parecían estar asociadas a menores tasas de hospitalización en comparación con los controles en las infecciones por SARS-CoV-2.

Newswise: Una encuesta revela que el 42 % de los médicos de atención primaria no están familiarizados con los productos biológicos para tratar el asma
3-Nov-2023 8:00 AM EDT
Una encuesta revela que el 42 % de los médicos de atención primaria no están familiarizados con los productos biológicos para tratar el asma
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentará en la Reunión Científica Anual del ACAAI de este año en Anaheim (California) muestra que el 42% de los médicos de atención primaria (PCP) encuestados no estaban familiarizados con los productos biológicos para tratar el asma.

Newswise: Survey Reveals 42% of Primary Care Physicians Are Unfamiliar with Biologics to Treat Asthma
3-Nov-2023 8:00 AM EDT
Survey Reveals 42% of Primary Care Physicians Are Unfamiliar with Biologics to Treat Asthma
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. shows that 42% of the primary care physicians (PCPs) surveyed were unfamiliar with asthma biologics.

Newswise: Special Toothpaste May Lower Risk of Allergic Reactions for Adults with Peanut Allergy
3-Nov-2023 8:00 AM EDT
Special Toothpaste May Lower Risk of Allergic Reactions for Adults with Peanut Allergy
American College of Allergy, Asthma and Immunology (ACAAI)

A new late breaking abstract being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. demonstrates that a specially formulated toothpaste can be successfully used for Oral Mucosal Immunotherapy (OMIT).

Released: 9-Nov-2023 8:00 AM EST
Vigorous Exercise, Rigorous Science: What Scientists Learned from Firefighters in Training
Pacific Northwest National Laboratory

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

Newswise: Antibodies to Cow’s Milk Linked to Increased Risk of Cardiovascular Death
9-Nov-2023 4:05 AM EST
Antibodies to Cow’s Milk Linked to Increased Risk of Cardiovascular Death
University of North Carolina Health Care System

Analyses led by Corinne Keet, MD, PhD, at the University of North Carolina School of Medicine, of two longitudinal studies reveal how an increased level of an antibody called immunoglobin (IgE) to cow’s milk is associated to cardiovascular-related death.

Newswise: Gender-neutral HPV vaccination best at preventing cervical cancer
Released: 8-Nov-2023 6:05 PM EST
Gender-neutral HPV vaccination best at preventing cervical cancer
Karolinska Institute

The most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study involving researchers from Karolinska Institutet published in Cell, Host and Microbe. Beside personal immunity, such use of the vaccine also induces a herd immunity that will help to eradicate the carcinogenic virus types more quickly.

Released: 8-Nov-2023 9:50 AM EST
Forward Therapeutics Announces $50 Million Series A Financing to Advance Next-Generation Small Molecule Immune Therapies
Forward Therapeutics

Forward Therapeutics, Inc., a biopharmaceutical company developing next-generation small molecule therapies for chronic immunological and inflammatory disorders, today announced a $50 million Series A financing.

   
5-Nov-2023 6:00 AM EST
Scientists engineer potent immune cells for ‘off-the-shelf’ cancer immunotherapy
University of California, Los Angeles (UCLA), Health Sciences

UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for “off-the-shelf” cell therapy to treat challenging cancers.

Released: 7-Nov-2023 1:05 PM EST
MSU working to help promote success of Type 1 diabetes treatments with support from JDRF
Michigan State University

JDRF, the world’s largest nonprofit supporter of Type 1 diabetes research, has awarded a $750,000 grant to a team of Michigan State University researchers.

Newswise: Immunotherapy effective on young children’s peanut allergies
Released: 7-Nov-2023 10:05 AM EST
Immunotherapy effective on young children’s peanut allergies
UT Southwestern Medical Center

Low doses of an immunotherapy taken under the tongue safely achieved desensitization to peanut allergies in children ages 1 to 4 years, according to results of a clinical trial conducted by researchers at UT Southwestern Medical Center, Children’s Medical Center Dallas, and the University of North Carolina School of Medicine.

Released: 6-Nov-2023 6:05 PM EST
Improving the efficacy of cancer immunotherapy with modified CAR-T cells
University of Freiburg

CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion.

Released: 6-Nov-2023 6:05 PM EST
Rakuten Medical Presents AI-based Study in Two Posters on Immune Characteristics in Responders and Cellular Level Drug Quantification of Alluminox Treatment (Photoimmunotherapy) at SITC 2023
Rakuten Medical, Inc.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeted therapies based on its proprietary Alluminox™ platform today announced the presentation of two posters of AI-based analyses at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), held November 3-5, 2023, in San Diego, CA (SITC 2023).

Released: 6-Nov-2023 10:00 AM EST
MD Anderson Research Highlights: SITC 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational, and clinical cancer research from MD Anderson experts. irectly into the liver for patients with metastatic uveal melanoma.

   
Newswise: Pathologic Scoring Shows Promise for Assessing Lung Tumor Therapy Response
2-Nov-2023 12:00 PM EDT
Pathologic Scoring Shows Promise for Assessing Lung Tumor Therapy Response
Johns Hopkins Medicine

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

Released: 3-Nov-2023 6:05 PM EDT
Novel approach promises significant advance in treating autoimmune brain inflammation
DZNE -- German Center for Neurodegenerative Diseases

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

Newswise: Some Benefits of Exercise Stem from the Immune System
1-Nov-2023 8:00 PM EDT
Some Benefits of Exercise Stem from the Immune System
Harvard Medical School

Research in mice shows that the anti-inflammatory properties of exercise may arise from immune cells mobilized to counter exercise-induced inflammation. Immune cells prevent muscle damage by lowering levels of interferon, a key driver of chronic inflammation, inflammatory diseases, and aging.

Released: 2-Nov-2023 10:50 AM EDT
New COVID-19 vaccine a good value for U.S., U-M team finds
Michigan Medicine - University of Michigan

A cost-effectiveness analysis for the updated COVID-19 vaccine prepared for the CDC's vaccine panel shows cost savings from vaccinating people over age 65, and good value from vaccinating adults of all ages.

Newswise: Jean-Laurent Casanova is Recipient of 2023 Maria I. New International Prize for Biomedical Research
Released: 31-Oct-2023 9:00 AM EDT
Jean-Laurent Casanova is Recipient of 2023 Maria I. New International Prize for Biomedical Research
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai will award its 2023 Maria I. New International Prize for Biomedical Research to Jean-Laurent Casanova, MD, PhD, for revolutionizing our understanding of human infectious diseases through the discovery of genetic and immunological determinants that underpin both rare and common infectious illnesses. The prize honors medical pioneers in the tradition of Maria I. New, MD, a world-renowned researcher in pediatric genetic disorders with a special focus on endocrinology over her six-decade career. Dr. Casanova will receive a prize of $20,000 and will present the Maria I. New Distinguished Lecture during a ceremony to be held in at Icahn Mount Sinai in New York City on November 21, 2023.

Newswise: Intestinal bacteria metabolite promotes capture of antigens by dendritic cells
Released: 30-Oct-2023 11:05 AM EDT
Intestinal bacteria metabolite promotes capture of antigens by dendritic cells
Okayama University

Dendritic cells play a key role in the mammalian immune system. These cells are present throughout the human body and are known to capture foreign bodies, i.e., antigens, using extendable “arms” called dendrites

Newswise: Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award
Released: 27-Oct-2023 2:45 PM EDT
Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award
Cancer Research Institute

The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.

26-Oct-2023 5:05 PM EDT
Find-and-Replace Genome Editing with CRISPR: A Promising Therapeutic Strategy
Bar-Ilan University

A novel replacement strategy termed GE x HDR 2.0: Find and Replace, developed by researchers from Bar-Ilan University and described in published today in Nature Communications, combines CRISPR-Cas9-mediated genome editing with recombinant adeno-associated serotype 6 (rAAV6) DNA donor vectors to precisely replace the RAG2 coding sequence while preserving regulatory elements.

Released: 25-Oct-2023 9:30 AM EDT
Rutgers Awarded NIH Grant to Study How Previous Infections Affect Immune Response to Lung Disease
Rutgers University-New Brunswick

Researchers will examine how the body’s adaptations to viruses, fungi and parasites change its ability to combat unrelated respiratory infections.

Newswise: Preliminary Data Support Novel Immunotherapy for Advanced Malignant Melanoma in Dogs
Released: 24-Oct-2023 5:05 PM EDT
Preliminary Data Support Novel Immunotherapy for Advanced Malignant Melanoma in Dogs
College of Veterinary Medicine, University of Illinois Urbana-Champaign

A clinical study of 11 dogs with advanced malignant melanoma demonstrated the efficacy, safety, and tolerability profile of cANK-101, a canine interleukin-12 anchored immunotherapy.

Released: 24-Oct-2023 12:05 PM EDT
How to slow the spread of deadly ‘superbugs’
University of Technology, Sydney

Harnessing new advances in genomic surveillance technology could help detect the rise of deadly ‘superbugs’

Released: 23-Oct-2023 6:05 PM EDT
Researchers identify ‘switch’ to activate cancer cell death
UC Davis Health

A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.



close
3.23913